Still calculating financial ratios manually?
Stop wasting time — let the computer do it!
Enfusion, Inc. (ENFN) Financial Analysis and Rating
Comparison Analysis Based on SEC Data
| Company Name | Enfusion, Inc. |
| Industry (SIC) | 7372 - Prepackaged Software |
| Revenue in 2024 | $201,611 thousand (ranked #334 out of 512 companies in the industry) |
| Assets as of 12/31/2024 | $143,261 thousand (ranked #366) |
| Analyzed report | 12/31/2023 (filed 3/12/2024) |
Year:
Financial Position and Performance
| Compared with 2023 industry ratios | Change during the year |
|---|---|
|
much better |
improved |
| Compared with all listed companies |
|---|
|
much better |
Financial Ratios Benchmarking
| Financial Ratio | Comparison of company ratios for 2023 | ||
|---|---|---|---|
|
with industry ratios (73 - Business Services) |
with all listed companies | ||
| Solvency Ratios | |||
| Debt ratio |
0.29
0.60
|
0.29
0.61
|
|
| Debt-to-equity ratio |
0.41
1.14
|
0.41
1.32
|
|
| Interest coverage ratio |
148.23
-0.52
|
148.23
1.62
|
|
| Liquidity Ratios | |||
| Current Ratio |
3.44
1.45
|
3.44
1.72
|
|
| Quick Ratio |
3.14
1.13
|
3.14
1.04
|
|
| Cash Ratio |
1.75
0.57
|
1.75
0.53
|
|
| Profitability Ratios | |||
| Profit margin |
3.5%
-6.4%
|
3.5%
2%
|
|
| ROE (Return on equity), after tax |
6.7%
-4%
|
6.7%
4%
|
|
| ROA (Return on assets) |
5.2%
-2.9%
|
5.2%
0.6%
|
|
| Activity Ratios | |||
| Asset turnover (days) |
243
605
|
243
786
|
|
| Receivables turnover (days) |
56
59
|
56
49
|
|
| Resulting score | +1,7 | +1,5 | |
Year:
Additional Ratios (not used in score calculation)
| Financial Ratio | Comparison of company ratios for 2023 | ||
|---|---|---|---|
|
with industry ratios (73 - Business Services) |
with all listed companies | ||
| Profitability Ratios | |||
| Gross margin |
67%
57.1%
|
67%
41%
|
|
| Operating margin (Return on sales) |
6.6%
-0.8%
|
6.6%
6.6%
|
|
| Activity Ratios | |||
| EBIT | $12M | ||
| EBITDA | $22M | ||
| Price Ratios | |||
| Earnings per Share (basic) | $0.07 | ||
| Earnings per Share (diluted) | $0.07 | ||
Auditor's Conclusion
We have performed a comparative analysis of the balance sheet and income statement of Enfusion, Inc. (hereafter – the "Company") for the year 2023 as filed with the U.S. Securities and Exchange Commission (SEC). The primary business activity of the Company is "Prepackaged Software" (SIC code 7372). In our analysis, we compared the key financial ratios of the Company with the average (median) values of those ratios